291 related articles for article (PubMed ID: 30885218)
21. Overactivated neddylation pathway as a therapeutic target in lung cancer.
Li L; Wang M; Yu G; Chen P; Li H; Wei D; Zhu J; Xie L; Jia H; Shi J; Li C; Yao W; Wang Y; Gao Q; Jeong LS; Lee HW; Yu J; Hu F; Mei J; Wang P; Chu Y; Qi H; Yang M; Dong Z; Sun Y; Hoffman RM; Jia L
J Natl Cancer Inst; 2014 Jun; 106(6):dju083. PubMed ID: 24853380
[TBL] [Abstract][Full Text] [Related]
22. Targeting NEDD8-activated cullin-RING ligases for the treatment of cancer.
Soucy TA; Smith PG; Rolfe M
Clin Cancer Res; 2009 Jun; 15(12):3912-6. PubMed ID: 19509147
[TBL] [Abstract][Full Text] [Related]
23. Caffeic acid phenethyl ester induced cell cycle arrest and growth inhibition in androgen-independent prostate cancer cells via regulation of Skp2, p53, p21Cip1 and p27Kip1.
Lin HP; Lin CY; Huo C; Hsiao PH; Su LC; Jiang SS; Chan TM; Chang CH; Chen LT; Kung HJ; Wang HD; Chuu CP
Oncotarget; 2015 Mar; 6(9):6684-707. PubMed ID: 25788262
[TBL] [Abstract][Full Text] [Related]
24. Targeting DCN1-UBC12 Protein-Protein Interaction for Regulation of Neddylation Pathway.
Zhou H; Lu J; Yang CY; Sun Y; Wang S
Adv Exp Med Biol; 2020; 1217():349-362. PubMed ID: 31898237
[TBL] [Abstract][Full Text] [Related]
25. Co-targeting SKP2 and KDM5B inhibits prostate cancer progression by abrogating AKT signaling with induction of senescence and apoptosis.
Brown LK; Kanagasabai T; Li G; Celada SI; Rumph JT; Adunyah SE; Stewart LV; Chen Z
Prostate; 2024 Jun; 84(9):877-887. PubMed ID: 38605532
[TBL] [Abstract][Full Text] [Related]
26. Discovery of 1,2,4-triazine-based derivatives as novel neddylation inhibitors and anticancer activity studies against gastric cancer MGC-803 cells.
Song J; Cui XX; Wu BW; Li D; Wang SH; Shi L; Zhu T; Zhang YB; Zhang SY
Bioorg Med Chem Lett; 2020 Jan; 30(2):126791. PubMed ID: 31740251
[TBL] [Abstract][Full Text] [Related]
27. A novel selenonucleoside suppresses tumor growth by targeting Skp2 degradation in paclitaxel-resistant prostate cancer.
Byun WS; Jin M; Yu J; Kim WK; Song J; Chung HJ; Jeong LS; Lee SK
Biochem Pharmacol; 2018 Dec; 158():84-94. PubMed ID: 30292755
[TBL] [Abstract][Full Text] [Related]
28. Targeting the oncogenic E3 ligase Skp2 in prostate and breast cancer cells with a novel energy restriction-mimetic agent.
Wei S; Chu PC; Chuang HC; Hung WC; Kulp SK; Chen CS
PLoS One; 2012; 7(10):e47298. PubMed ID: 23071779
[TBL] [Abstract][Full Text] [Related]
29. Pharmacogenomics and chemical library screens reveal a novel SCF
Malek E; Abdel-Malek MA; Jagannathan S; Vad N; Karns R; Jegga AG; Broyl A; van Duin M; Sonneveld P; Cottini F; Anderson KC; Driscoll JJ
Leukemia; 2017 Mar; 31(3):645-653. PubMed ID: 27677741
[TBL] [Abstract][Full Text] [Related]
30. Characterization of cullin-based E3 ubiquitin ligases in intact mammalian cells--evidence for cullin dimerization.
Chew EH; Poobalasingam T; Hawkey CJ; Hagen T
Cell Signal; 2007 May; 19(5):1071-80. PubMed ID: 17254749
[TBL] [Abstract][Full Text] [Related]
31. Control of the SCF(Skp2-Cks1) ubiquitin ligase by the APC/C(Cdh1) ubiquitin ligase.
Bashir T; Dorrello NV; Amador V; Guardavaccaro D; Pagano M
Nature; 2004 Mar; 428(6979):190-3. PubMed ID: 15014502
[TBL] [Abstract][Full Text] [Related]
32. Antibody-free detection of cellular neddylation dynamics of Cullin1.
Schwinn MK; Hoang T; Yang X; Zhao X; Ma J; Li P; Wood KV; Mallender WD; Bembenek ME; Yan ZH
Anal Biochem; 2018 Aug; 555():67-72. PubMed ID: 29733811
[TBL] [Abstract][Full Text] [Related]
33. A first-in-class inhibitor, MLN4924 (pevonedistat), induces cell-cycle arrest, senescence, and apoptosis in human renal cell carcinoma by suppressing UBE2M-dependent neddylation modification.
Xu B; Deng Y; Bi R; Guo H; Shu C; Shah NK; Chang J; Liu G; Du Y; Wei W; Wang C
Cancer Chemother Pharmacol; 2018 Jun; 81(6):1083-1093. PubMed ID: 29667067
[TBL] [Abstract][Full Text] [Related]
34. Flavokawain B, a kava chalcone, inhibits growth of human osteosarcoma cells through G2/M cell cycle arrest and apoptosis.
Ji T; Lin C; Krill LS; Eskander R; Guo Y; Zi X; Hoang BH
Mol Cancer; 2013 Jun; 12():55. PubMed ID: 23764122
[TBL] [Abstract][Full Text] [Related]
35. The In Vitro and In Vivo Antiangiogenic Effects of Flavokawain B.
Rossette MC; Moraes DC; Sacramento EK; Romano-Silva MA; Carvalho JL; Gomes DA; Caldas H; Friedman E; Bastos-Rodrigues L; De Marco L
Phytother Res; 2017 Oct; 31(10):1607-1613. PubMed ID: 28816367
[TBL] [Abstract][Full Text] [Related]
36. The role of SCF
Yamashita M; Owa T; Shiraishi R; Adachi T; Ichijo K; Taya S; Miyashita S; Hoshino M
Genes Cells; 2020 Dec; 25(12):796-810. PubMed ID: 33020978
[TBL] [Abstract][Full Text] [Related]
37. The COP9 signalosome regulates Skp2 levels and proliferation of human cells.
Denti S; Fernandez-Sanchez ME; Rogge L; Bianchi E
J Biol Chem; 2006 Oct; 281(43):32188-96. PubMed ID: 16943200
[TBL] [Abstract][Full Text] [Related]
38. In vivo antitumor and antimetastatic effects of flavokawain B in 4T1 breast cancer cell-challenged mice.
Abu N; Mohamed NE; Yeap SK; Lim KL; Akhtar MN; Zulfadli AJ; Kee BB; Abdullah MP; Omar AR; Alitheen NB
Drug Des Devel Ther; 2015; 9():1401-17. PubMed ID: 25834398
[TBL] [Abstract][Full Text] [Related]
39. NNMT/1-MNA Promote Cell-Cycle Progression of Breast Cancer by Targeting UBC12/Cullin-1-Mediated Degradation of P27 Proteins.
Ma Y; Huang X; Wang Y; Lei Y; Yu J; Yu S; Gao Y; Yang J; Zhao F; Yu H; Zeng J; Chu Y; Yang M; Li G; Xie X; Zhang J
Adv Sci (Weinh); 2024 Mar; 11(9):e2305907. PubMed ID: 38126621
[TBL] [Abstract][Full Text] [Related]
40. CD28 costimulation mediates transcription of SKP2 and CKS1, the substrate recognition components of SCFSkp2 ubiquitin ligase that leads p27kip1 to degradation.
Appleman LJ; Chernova I; Li L; Boussiotis VA
Cell Cycle; 2006 Sep; 5(18):2123-9. PubMed ID: 16969077
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]